Bin Wu

Bin Wu

Company: Amgen Inc.

Job title: Principal Scientist


Exploring the Development of AMG 133: Utilizing GLP-1 Agonist Peptides to Tackle Obesity 12:00 pm

Exploring site-specific conjugation of peptides to monoclonal antibodies Improving metabolic stability of bispecific conjugates through antibody and peptide engineering Identifying clinical candidate for the treatment of obesity using preclinical modelsRead more

day: Pre-Conference Day Track 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.